M E D G O A I

Loading

shape-img
shape-img
shape-img
shape-img
shape-img
shape-img

Leading De Novo
Drug Design

Leverage out cutting-edge technology with AI-aided computational chemistry and
biology to design drug lead compounds with better drug-like properties
and binding affinity to proteins in silico predictions.

shape-img
shape-img
shape-img
shape-img

Empowering Health
on the Streets

AI-Driven Support for Locating Care and
Receiving Critical Consultations.

shape-img
shape-img
about-img
icon ABOUT MedGoAI icon

Leading De Novo Drug Design

Leverage out cutting-edge technology with AI-aided computational chemistry and biology to design drug lead compounds with better drug-like properties and binding affinity to proteins in silico predictions.

icon Platform icon

Our innovative platform

thumb
Allo-DiffHopping
Protein-ligand Interactions
thumb
HealthStation
Open Access
shape-img
shape-img
icon Team Members icon

Our Dedicated Team Members

team-img

Victor Li

Founder, CEO